日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Integrative clinico-molecular analysis reveals actionable subtypes and biomarkers in lung adenocarcinoma.

综合临床分子分析揭示肺腺癌中可操作的亚型和生物标志物。

期刊:Cell Discovery
影响因子:12.5
doi:10.1038/s41421-025-00863-4
Shang Jun, Jiang He, Yan Yueren, Zhao Yue, Yang Jingcheng, Han Han, Yuan Hui, Shi Leming, Zheng Yuanting, Chen Haiquan
肿瘤
发表日期：2026
文献求助 收藏

Evolutionary proteogenomic landscape from pre-invasive to invasive lung adenocarcinoma

从癌前到癌变肺腺癌的进化蛋白质基因组图谱

期刊:Cell Reports Medicine
影响因子:10.6
doi:10.1016/j.xcrm.2026.102590
Zhang, Yang; Fu, Fangqiu; Zhang, Qiao; Li, Lingling; Liu, Hui; Deng, Chaoqiang; Xue, Qianqian; Zhao, Yue; Sun, Wenrui; Han, Han; Gao, Zhendong; Guo, Chunmei; Zheng, Qiang; Hu, Hong; Sun, Yihua; Li, Yuan; Ding, Chen; Chen, Haiquan
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Integrated multi-omics analysis reveals GPD1L-mediated dysregulation of glycerophospholipid metabolism facilitates the progression of lung adenocarcinoma.

综合多组学分析揭示 GPD1L 介导的甘油磷脂代谢失调促进肺腺癌的进展。

期刊:Respiratory Research
影响因子:5
doi:10.1186/s12931-026-03558-w
Sun Yifu, Yan Yueren, Zhou Yudi, Chen Yuting, Liu Chunnan, Bao Yufang, Zhang Yang, Han Han, Chen Haiquan
代谢
脂代谢
发表日期：2026
文献求助 收藏

Proposal on incorporating consolidation-to-tumor ratio into the clinical T1 classification in patients with invasive lung adenocarcinoma

关于将实变与肿瘤比例纳入浸润性肺腺癌患者临床T1分期的提议

期刊:Translational Lung Cancer Research
影响因子:3.5
doi:10.21037/tlcr-2025-aw-1274
Zhang, Molin; Deng, Chaoqiang; Fu, Fangqiu; Ye, Ting; Turna, Akif; Li, Yuan; Zhang, Yang; Chen, Haiquan
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

A Subgroup Analysis of Perioperative Pembrolizumab in Clinical Stage II Non-Small-Cell Lung Cancer from the Randomized KEYNOTE-671 Study

来自 KEYNOTE-671 随机研究的围手术期帕博利珠单抗治疗 II 期非小细胞肺癌的亚组分析

期刊:European Journal of Cardio-Thoracic Surgery
影响因子:3
doi:10.1093/ejcts/ezag028
Tsuboi, Masahiro; Wakelee, Heather; Garassino, Marina C; Gao, Shugeng; Luft, Alexander; Chen, Ke-Neng; Spicer, Jonathan D; Zhu, Yuming; Saji, Hisashi; Okada, Morihito; Vanakesa, Tõnu; Chen, Haiquan; Zhao, Guofang; Ikeda, Norihiko; Jones, David R; Weksler, Benny; Huang, Chien-Sheng; Jensen, Erin; Keller, Steven M; Samkari, Ayman; Liberman, Moishe
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Postoperative chemoradiotherapy for esophageal squamous cell Carcinoma: Results from ESO-Shanghai 17 and joint analyses for phase II clinical trials

食管鳞状细胞癌术后放化疗：ESO-上海 17 研究结果及 II 期临床试验联合分析

期刊:Clinical and Translational Radiation Oncology
影响因子:2.7
doi:10.1016/j.ctro.2025.101073
Shen, Jingyi; Ai, Dashan; Chen, Yun; Liu, Qi; Deng, Jiaying; Hao, Shengnan; Zhang, Xiaofei; Zhang, Junhua; Zhang, Yutong; Chu, Li; Sun, Yihua; Zhang, Yawei; Xiang, Jiaqing; Miao, Longsheng; Chen, Haiquan; Zhu, Hongcheng; Zhao, Kuaile
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Comprehensive genomic and transcriptomic analyses reveal prognostic stratification for esophageal squamous cell carcinoma.

综合基因组和转录组分析揭示了食管鳞状细胞癌的预后分层

期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-025-02306-8
Gao Jian, Wang Qiming, Fu Fangqiu, Zhao Yue, Yang Teng, Li Xiangze, Sun Yihua, Hu Hong, Ma Longfei, Miao Longsheng, Luo Xiaoyang, Ye Ting, Zhang Yiliang, Zhang Yang, Huang Ziling, Li Hang, Shao Longlong, Xu Midie, Zhao Kuaile, Zhang Shiyue, Zhang Mou, Wang Jun, Dai Chong, Shang Xiaoxiao, An Tingyi, Zhang Yawei, Xiang Jiaqing, Cao Zhiwei, Li Bin, Chen Haiquan
细胞生物学
肿瘤免疫
发表日期：2025
文献求助 收藏

Phase III Study of Mediastinal Lymph Node Dissection for Ground Glass Opacity-Dominant Lung Adenocarcinoma

纵隔淋巴结清扫术治疗磨玻璃影为主型肺腺癌的III期研究

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-25-00610
Zhang, Yang; Qian, Bin; Song, Qingping; Ma, Junjie; Cao, Hang; Deng, Chaoqiang; Wang, Shengping; Ye, Ting; Xiang, Jiaqing; Zhang, Yawei; Sun, Yihua; Yan, Yueren; Zheng, Shanbo; Wu, Haoxuan; Huang, Qingyuan; Hu, Hong; Li, Yuan; Fu, Fangqiu; Chen, Haiquan
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Genomic and transcriptomic dynamics in the stepwise progression of lung adenocarcinoma.

肺腺癌逐步进展过程中的基因组和转录组动态变化。

期刊:Cell Research
影响因子:25.9
doi:10.1038/s41422-025-01200-w
Fu Fangqiu, Shang Jun, Yan Yueren, Jiang He, Han Han, Yuan Hui, Gao Zhendong, Yang Jingcheng, Gao Jian, Wang Jun, Pan Yunjian, Lin Yicong, Ye Ting, Zhang Yiliang, Zhang Yawei, Xiang Jiaqing, Hu Hong, Cao Zhiwei, Zheng Yuanting, Li Yuan, Zhang Yang, Jin Li, Shi Leming, Chen Haiquan
肿瘤
发表日期：2025
文献求助 收藏

Author Correction: Lung cancer deficient in the tumor suppressor GATA4 is sensitive to TGFBR1 inhibition

作者更正：缺乏抑癌基因GATA4的肺癌对TGFBR1抑制剂敏感。

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-63723-5
Gao, Lei; Hu, Yong; Tian, Yahui; Fan, Zhenzhen; Wang, Kun; Li, Hongdan; Zhou, Qian; Zeng, Guandi; Hu, Xin; Yu, Lei; Zhou, Shiyu; Tong, Xinyuan; Huang, Hsinyi; Chen, Haiquan; Liu, Qingsong; Liu, Wanting; Zhang, Gong; Zeng, Musheng; Zhou, Guangbiao; He, Qingyu; Ji, Hongbin; Chen, Liang
肺癌
肿瘤
肿瘤免疫
GATA
发表日期：2025
文献求助 收藏